Western regions will remain in the mix and the parameters of particular trials will continue to require regions other than the emerging markets, for regulatory and marketing purposes.What is the greatest problem faced by the contract research sector today, and how does that compare with the issues when Chiltern first opened its doors?Broadly speaking, I think the challenges remain the same, althou